by Wallace Garneau,America Outloud:
Dr. Peter McCullough and oncologist Dr. Wafik El Deiry, following the publication of his Oncotarget review (Kuperwasser & El Deiry 2026) entitled “COVID vaccination and post-infection cancer signals.” Dr. El-Deiry is the Director of the Cancer Center at Brown University, founding co-editor-in-chief of Oncotarget, and internationally recognized for discovering the WAF1/p21 gene and TRAIL death receptor 5.
TRUTH LIVES on athttps://sgtreport.tv/
El Deiry explained he had become concerned through: 1) Reports of hematologic and solid tumors arising shortly after infection or vaccination, 2) Biological plausibility based on known viral–oncogenic interactions (e.g., HPV, EBV), 3) His own P53 research, showing that SARS CoV 2 spike protein suppresses p53 dependent transcription and reduces tumor cell sensitivity to chemotherapy agents (cisplatin, 5 FU).
El-Deiry’s review compiled 69 publications describing post-vaccine or post-infection cancers (333 patients / 27 countries). He observed rapid progression, recurrence, and reactivation of otherwise stable disease (“turbo cancers”).
Both doctors suggested important next steps. Establish forensic tumor registries testing for mRNA, Spike, and nucleocapsid proteins (e.g., IHC + RT qPCR). Create assays for circulating spike levels; presently, no FDA-cleared test exists worldwide. Stratify risk by number of boosters and prior infection—possible threshold effects beyond 3–4 doses/episodes of infection. Focus immediate studies on high dose recipients (≥ 5–6 boosters) and unusual early onset cancers.
There is little chance mRNA technology could have future value in the absence of safety testing for oncogenicity. Both rejected personal“anti-vax”labels and endorsed true informed consent grounded in ongoing data collection. Consensus that“science must permit questions without persecution.”
Source: SGT Report
